Skip to main content

Table 2 Summary of primary and secondary outcome measures

From: High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial

Phase

Outcome measure

Timing

 

Day 0

Change in end expiratory lung impedance (∆EELI)

6 h

Primary outcome

Day 0

Change in end expiratory lung impedance (∆EELI)

15 min, 60 min, and 3 h

Secondary outcomes

Change in Tidal impedance variation (∆VARt)

0, 60 min, 3 h, and 6 h

Change in oxygenation (PaO2/FiO2)

Change in arterial CO2 (PaCO2)

Change in respiratory rate

Change in modified Borg dyspnoea score

Requirement for escalation of O2 therapy

Discharge

Length of ICU stay

Day 2–3

Re-admission to ICU

Length of hospital stay

Diagnosis of a respiratory complication

Follow up

Hospital re-admission

Week 6

Diagnosis of a respiratory complication

  1. EELI end expiratory lung impendence, PaO2/FiO2 arterial partial pressure of oxygen/fraction of inspired oxygen; PaCO2 arterial partial pressure of carbon dioxide